The Next Generation Biotech Media
February 27th, 2021 – Just a day after the FDA advisory panel’s unanimous recommendation, the US Food and Drug Administration (USFDA) has issued an emergency use authorization (EUA) for Johnson …
Read More
February 26th, 2021 – Johnson & Johnson has received endorsement from the Vaccines and Related Biological Products Advisory Committee (VRBPAC) for its single-shot COVID-19 vaccine, Ad26.COV2.S. The panel that convened …
Read More
February 24th, 2021 – The US Food and Drug Administration (USFDA) staff has deemed Johnson & Johnson’s single-shot COVID-19 vaccine safe and effective. In a briefing document published on Wednesday morning, …
Read More
Approved as an anti-flu drug in 2014 in Japan, Avigan (favipiravir) was repurposed by Japan’s Fujifilm Holdings Corp (Fujifilm) to treat COVID-19 patients in 2020. The drug is considered a …
Read More
On February 17, Japan launched the COVID-19 inoculation plan, prioritizing 40,000 frontline medical workers in 100 hospitals to be vaccinated with Pfizer/BioNTech’s COVID-19 vaccine that received the first emergency approval …
Read More
On February 9th, Eli Lilly announced receiving the FDA’s emergency use authorization for its COVID-19 combination therapy comprising bamlanivimab and etesevimab. The approval was based on data from the Phase …
Read More
On February 7th, the South African government decided to put the AstraZeneca vaccinations on hold after the COVID-19 vaccine was only 22% effective at preventing mild-to-moderate infections caused by the …
Read More
Vaccine is one of the best weapons to tackle the COVID-19 pandemic, but it still needs a close examination of efficacy and safety to receive government approval. COVID-19 detection devices …
Read More
On February 2nd, results from a Phase 3 clinical trial showed the Sputnik V vaccine, developed by the Gamaleya Institute in Moscow, was 91.6% effective against COVID-19. The vaccine was …
Read More
China’s COVID-19 vaccine developer Clover Biopharmaceuticals has been testing two adjuvants, one from Dynavax and the other from GSK, on its vaccine in the early stages of trials. On February …
Read More